Testing effectiveness (Phase 2)Ended earlyNCT00508651
What this trial is testing
A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age
Who this might be right for
Healthy
MedImmune LLC 30